15,495 Shares in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Acquired by Inceptionr LLC

Inceptionr LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 15,495 shares of the company's stock, valued at approximately $614,000.

Several other institutional investors have also recently bought and sold shares of ACHC. Blue Trust Inc. lifted its stake in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after acquiring an additional 345 shares during the last quarter. Nisa Investment Advisors LLC boosted its stake in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Covestor Ltd grew its holdings in shares of Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company's stock worth $72,000 after purchasing an additional 1,018 shares during the last quarter. Fifth Third Bancorp increased its stake in shares of Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock valued at $50,000 after buying an additional 454 shares during the period. Finally, Assetmark Inc. raised its holdings in Acadia Healthcare by 66.1% in the 3rd quarter. Assetmark Inc. now owns 1,485 shares of the company's stock valued at $94,000 after buying an additional 591 shares during the last quarter.

Acadia Healthcare Trading Down 2.5 %

ACHC traded down $0.75 during trading on Tuesday, hitting $29.12. The company's stock had a trading volume of 1,240,319 shares, compared to its average volume of 1,865,083. The firm has a market capitalization of $2.71 billion, a P/E ratio of 9.55, a PEG ratio of 1.46 and a beta of 1.38. Acadia Healthcare Company, Inc. has a twelve month low of $28.09 and a twelve month high of $82.40. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock's fifty day moving average price is $41.14 and its 200-day moving average price is $49.72.

Remove Ads

Analyst Ratings Changes

Several equities analysts have issued reports on ACHC shares. TD Cowen decreased their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Bank of America cut their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. StockNews.com cut Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Finally, Royal Bank of Canada cut their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $56.31.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.